NWCR Seminar Series - Evangelos Giampazolias
1:00pm - 2:00pm /
Tuesday 18th November 2025
/ Venue: Physiology Seminar Room Nuffield Wing
Type: Seminar /
Category: Department
/ Series: Institute of Systems, Molecular and Integrative Biology
- Ainhoa Mielgo
- Admission: Free
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Evangelos Giampazolias received his BSc in Chemistry (2009) and MSc in Clinical Biochemistry (2012) from the University of Athens in Greece.
In 2012, he moved to Glasgow, UK, for his PhD at the Cancer Research UK (CRUK) Scotland Institute under the supervision of Professor Stephen Tait.
During his PhD, he studied the signaling cascades that link cell death modalities regulated by mitochondria to cancer immunity. For this, he was awarded
the Institute of Cancer Sciences Prize (2017) and the CRUK Pontecorvo Prize (2018). Evangelos subsequently joined the group of Professor Caetano Reis e Sousa at the Francis Crick Institute in London, UK, as a Postdoctoral Fellow to study how detection of dying tumour cells by receptors expressed on dendritic cells elicit immunity to cancer. He was granted an innovation patent (2020) to explore the therapeutic potential of his findings as novel immunotherapies for cancers.
During the transition to his current independent position, Evangelos identified host-microbiome interactions that shape immune responses to extraintestinal tumours.
In 2023, Evangelos funded by a CRUK Institute Award and a Royal Society Research Grant established the Cancer Immunosurveillance group at the CRUK Manchester Institute, which focuses on the characterisation of the mechanisms underlying immune defence against cancer following host detection of signals derived from dead cells and commensal microbes.
In 2024, Evangelos was awarded an ERC Starting Grant to expand his latest discoveries and study the mechanisms that couple nutrient-host-microbiome interactions to cancer immunity. In recognition of the translational impact of his research, he received the British BACR/AstraZeneca Young Scientist Frank Rose Award in 2025.
If you would like to meet with Evangelos, please contact the host Ainoha Mielgo (amielgo@liverpool.ac.uk).
In 2012, he moved to Glasgow, UK, for his PhD at the Cancer Research UK (CRUK) Scotland Institute under the supervision of Professor Stephen Tait.
During his PhD, he studied the signaling cascades that link cell death modalities regulated by mitochondria to cancer immunity. For this, he was awarded
the Institute of Cancer Sciences Prize (2017) and the CRUK Pontecorvo Prize (2018). Evangelos subsequently joined the group of Professor Caetano Reis e Sousa at the Francis Crick Institute in London, UK, as a Postdoctoral Fellow to study how detection of dying tumour cells by receptors expressed on dendritic cells elicit immunity to cancer. He was granted an innovation patent (2020) to explore the therapeutic potential of his findings as novel immunotherapies for cancers.
During the transition to his current independent position, Evangelos identified host-microbiome interactions that shape immune responses to extraintestinal tumours.
In 2023, Evangelos funded by a CRUK Institute Award and a Royal Society Research Grant established the Cancer Immunosurveillance group at the CRUK Manchester Institute, which focuses on the characterisation of the mechanisms underlying immune defence against cancer following host detection of signals derived from dead cells and commensal microbes.
In 2024, Evangelos was awarded an ERC Starting Grant to expand his latest discoveries and study the mechanisms that couple nutrient-host-microbiome interactions to cancer immunity. In recognition of the translational impact of his research, he received the British BACR/AstraZeneca Young Scientist Frank Rose Award in 2025.
If you would like to meet with Evangelos, please contact the host Ainoha Mielgo (amielgo@liverpool.ac.uk).